MAYO CLINIC: $32.4M Department of Health and Human Services Federal Award
Summary
The NIH awarded Mayo Clinic a $32.4M contract for continued biobank operations for the All of Us precision medicine program. As a private entity, no publicly traded companies directly benefit, but the contract underscores continued federal investment in precision medicine infrastructure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Mayo Clinic continues as lead biobank for All of Us program.
- 2.Precision medicine remains a federal priority.
- 3.No direct public company beneficiary from this contract.
Market Implications
This contract does not move any publicly traded stocks. The All of Us program's continued funding indicates steady demand for biobanking services, which could benefit private companies like LabCorp or Quest in related areas, but this contract is exclusive to Mayo Clinic.
Full Analysis
The Department of Health and Human Services, through the National Institutes of Health, awarded a $32.4M direct financial aid contract to Mayo Clinic to sustain and expand the All of Us Research Program's biobank. The contract covers 2025-2027 and aims to maintain biospecimen collection, storage, distribution, and support pediatric and ancillary studies. Mayo Clinic is a private non-profit academic medical center, not a publicly traded company. No public company is the direct recipient, parent, or recognized subsidiary. While precision medicine initiatives broadly benefit healthcare research, this specific contract does not flow directly to any public company.
No related bills from the provided list show a direct connection to this biobank contract. Most bills are neutral with low impact and cover disparate sectors like manufacturing, infrastructure, or defense. The contract is a continuation of a program established in 2017, and similar awards for biobanking have historically been renewed without immediate public market implications.
Because the recipient is private, no supply chain or competitor analysis is warranted per guidelines—guessing would produce false positives. Investors should note the ongoing federal commitment to precision medicine but recognize that this contract's value is not linked to any publicly traded equity.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
MAYO CLINIC
Award Amount
$32,432,744
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DIRECT PAYMENT FOR SPECIFIED USE, AS A SUBSIDY OR OTHER NON-REIMBURSABLE DIRECT FINANCIAL AID (C)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →